McKesson, CD&R agree to buy Option Care Health for $32.05 a share in $5.8 billion deal
Bitget2026/10/06 12:03CD&R, McKesson, and Option Care Health agreed to acquire Option Care Health for USD 32.05 per share. Deal values Option Care Health at about USD 5.8 billion enterprise value. CD&R to hold about 51% at close; McKesson to invest about USD 1.4 billion for about 49%. Option Care Health expected to remain a separate company under its existing management team. Closing targeted for the first half of calendar 2027; Option Care Health shares to be delisted, making it privately held. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. McKesson Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 20261005837505) on October 06, 2026, and is solely responsible for the information contained therein.
- CD&R, McKesson, and Option Care Health agreed to acquire Option Care Health for USD 32.05 per share.
- Deal values Option Care Health at about USD 5.8 billion enterprise value.
- CD&R to hold about 51% at close; McKesson to invest about USD 1.4 billion for about 49%.
- Option Care Health expected to remain a separate company under its existing management team.
- Closing targeted for the first half of calendar 2027; Option Care Health shares to be delisted, making it privately held.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BUZZ - Jefferies bullish on US cruise sector; Royal Caribbean rises on rating upgrade
October 8th - ** Shares of U.S. cruise company Royal Caribbean (RCL.N) rose 1.2% in pre-market trading to $285.85 ** Jefferies upgraded RCL from "Hold" to "Buy" and raised its price target from $305 to $330 ** The firm also raised its price target for Lindblad Expeditions Holdings (LIND.O) from $29 to $32; LIND shares were flat pre-market ** "We are optimistic about the long-term prospects of the cruise industry as its share in the global vacation market continues to grow," said Jefferies ** The firm noted significant upside in the sector given strong revenue performance ** "We also believe that in the 2027 fiscal year, cruise stocks will be very attractive value investments under various macroeconomic scenarios, with land-based travel products providing additional growth momentum for earnings," Jefferies added ** As of the previous trading day’s close, RCL shares had risen 1.2% and LIND is up 143% year-to-date
Deutsche Bank: Changes in Investor Positions and Capital Flows
New Generation of Crypto Miners Released by ASICID
BUZZ - Levi Strauss shares drop due to weak sales in the US and Europe
On October 8, Levi Strauss (LEVI.N) shares fell 1.3% in pre-market trading to $19.25 after the company reported lower-than-expected sales in the U.S. and Europe. BTIG commented: “This quarter, the European direct-to-consumer (DTC) business was hit by unusually warm weather, but as temperatures return to normal, foot traffic and sales trends have improved, maintaining a positive outlook in early Q4.” The brokerage also noted that the company remains strong in wholesale, e-commerce, and market share in jeans, but its “back-to-school” marketing campaign did not meet expectations. Benefiting from tariff refunds on Wednesday, the company raised its annual profit forecast and is betting on strong demand for its premium jeans and sweaters during the holiday season. Sixteen analysts have an average “buy” rating; the median price target is $27, according to LSEG. The stock has risen 6% year-to-date as of the previous close.
Crypto prices
More
